PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder

International Journal of Neuropsychopharmacology

Volumn 14, Issue 2, 2011, Pages 237-245

  Schuhmacher, Anna ^a   Mössner, Rainald ^a   Höfels, Susanne ^a   Pfeiffer, Ute ^a   Guttenthaler, Vera ^a   Wagner, Michael ^a   Schwab, Sibylle G ^a,b   Maier, Wolfgang ^a   Zobel, Astrid ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dex CRH test; HPA; PCLO; rs2522833; unipolar depression

Indexed keywords

ASTRESSIN; CITALOPRAM; DEXAMETHASONE; MIRTAZAPINE; NORTRIPTYLINE;

ADULT; ALLELE; ARTICLE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PICCOLO ENCODING GENE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; ALLELES; ANTIDEPRESSIVE AGENTS; AREA UNDER CURVE; CORTICOTROPIN-RELEASING HORMONE; CYTOSKELETAL PROTEINS; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES;

EID: 79952746788     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000854     Document Type: Article

References (34)

1. Baghai TC, Schule C, Zwanzger P, Minov C, et al. (2002). Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neuroscience Letters 328, 299-303. (Pubitemid 34876670)
2. Binder EB, Salyakina D, Lichtner P, Wochnik GM, et al. (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, 1319-1325. (Pubitemid 39577942)
3. Bochdanovits Z, Verhage M, Smit AB, de Geus EJ, et al. (2009). Joint reanalysis of 29 correlated SNPs supports the role of PCLO/Piccolo as a causal risk factor for major depressive disorder. Molecular Psychiatry 14, 650-652.
4. Brouwer JP, Appelhof BC, van Rossum EF, Koper JW, et al. (2006). Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 31, 1154-1163. (Pubitemid 44803086)
5. Derijk RH (2009). Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 16, 340-352.
6. Derijk RH, de Kloet ER (2008). Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. European Journal of Pharmacology 583, 303-311.
7. Drago A, De Ronchi D, Serretti A (2009). Pharmacogenetics of antidepressant response: an update. Human Genomics 3, 257-274.
8. Erdfelder E, Faul F, Buchner A (1996). GPOWER: a general power analysis program. Behavior Research Methods, Instruments, & Computers 28, 1-11. (Pubitemid 126416697)
9. Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 56-62.
10. Hek K, Mulder CL, Luijendijk HJ, van Duijn CM, et al. (2009). The PCLO gene and depressive disorders: replication in a population-based study. Human Molecular Genetics 19, 731-734.
11. Heuser I, Schweiger U, Gotthardt U, Schmider J, et al. (1996). Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry 153, 93-99. (Pubitemid 26026163)
12. Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 28, 341-356. (Pubitemid 24370022)
13. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477-501.
14. Holsboer F (2001). Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. Journal of Affective Disorders 62, 77-91. (Pubitemid 32126613)
15. Horstmann S, Binder EB (2009). Pharmacogenomics of antidepressant drugs. Pharmacology & Therapeutics 124, 57-73.
16. Horstmann S, Lucae S, Menke A, Hennings JM, et al. (2010). Polymorphisms in gRIK4, hTR2A, and fKBP5 show interactive effects in predicting remission to antidepressant treatment. Neuropsychopharmacology 35, 727-740.
17. Ising M, Kunzel HE, Binder EB, Nickel T, et al. (2005). The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29, 1085-1093. (Pubitemid 41080135)
18. Kraft JB, Peters EJ, Slager SL, Jenkins GD, et al. (2007). Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biological Psychiatry 61, 734-742. (Pubitemid 46330243)
19. Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, et al. (1990). 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biological Psychiatry 28, 620-628. (Pubitemid 20312947)
20. Li Q, Wichems C, Heils A, Van De Kar LD, et al. (1999). Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. Journal of Pharmacology and Experimental Therapeutics 291, 999-1007.
21. Markopoulou K, Papadopoulos A, Juruena MF, Poon L, et al. (2009). The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 34, 19-26.
22. McKay MS, Zakzanis KK (2010). The impact of treatment on HPA axis activity in unipolar major depression. Journal of Psychiatric Research 44, 183-192.
23. Muglia P, Tozzi F, Galwey NW, Francks C, et al. (2010). Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Molecular Psychiatry 15, 589-601.
24. Nikisch G (2009). Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuroendocrinology Letters 30, 11-16.
25. Schosser A, Kasper S (2009). The role of pharmacogenetics in the treatment of depression and anxiety disorders. International Clinical Psychopharmacology 24, 277-288.
26. Shelton RC (2007). The molecular neurobiology of depression. Psychiatric Clinics of North America 30, 1-11. (Pubitemid 46386302)
27. Sullivan PF, de Geus EJ, Willemsen G, James MR, et al. (2009). Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Molecular Psychiatry 14, 359-375.
28. Tsai SJ, Hong CJ, Chen TJ, Yu YW (2007). Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 144B, 1097-1098. (Pubitemid 350207789)
29. Uher R, Huezo-Diaz P, Perroud N, Smith R, et al. (2009). Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics Journal 9, 225-233.
30. Wittchen HU, Zaudig M, Fydrich T (1997). Strukturiertes klinisches interview für DSM-IV (SKID-I und SKID-II). Achse I: psychische; störungen/Achse II: persönlichkeitsstörungen. Göttingen, Bern, Toronto, Seattle: Hogrefe.
31. Zobel A, Jessen F, von Widdern O, Schuhmacher A, et al. (2008). Unipolar depression and hippocampal volume: impact of DNA sequence variants of the glucocorticoid receptor gene. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 147B, 836-843.
32. Zobel A, Maier W (2010). Pharmacogenetics of antidepressive treatment. European Archives of Psychiatry and Clinical Neuroscience. Published online: 3 January 2010. doi:10.1007/s00406-009-0091-4.
33. Zobel A, Nickel T, Sonntag A, Uhr M, et al. (2001). Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. Journal of Psychiatric Research 35, 83-94. (Pubitemid 32506751)
34. Zobel A, Schuhmacher A, Jessen F, Hoefels S, et al. (2010). DNA sequence variants of the FKBP5 gene are associated with unipolar depression. International Journal of Neuropsychopharmacology 13, 649-660.